---
figid: PMC5301050__nihms841624f1
figlink: /pmc/articles/PMC5301050/figure/F1/
number: F1
caption: 'Latency reversing agents (LRAs) that induce HIV expression in latently infected
  cells include histone deacetylase inhibitors (HDACi), bromodomain and extra-terminal
  (BET) inhibitors, methylation inhibitors and protein kinase C (PKC) agonists. HDACi
  promote histone acetylation and chromatin remodelling at the HIV promoter to support
  access for transcription initiation. Methylation inhibitors prevent deleterious
  hypermethylation of CpG islands near the HIV promoter to foster HIV transcription
  initiation. PKC agonists (eg. prostratin, bryostatin) promote the accumulation of
  active cellular NF-κB transcription factor in the cell nucleus to promote HIV transcription
  initiation. Bromodomain inhibitors (eg. JQ1) prevent PTEF-b binding to bromodomain
  proteins, releasing free PTEF-b to interact with HIV Tat protein for efficient HIV
  transcription elongation. Apoptosis-inducing compounds act on various pathways leading
  to caspase activation and apoptosis and could also be administered with LRAs to
  sensitise cells for apoptosis. For instance, acitretin triggers retinoic acid-inducible
  gene I (RIG-I) that in turn detects viral RNA for subsequent interferon-induced
  apoptosis. SMAC mimetics block inhibitor of apoptosis (IAP) proteins, preventing
  IAPs from inhibiting apoptosis and sensitizing cells towards apoptosis. Similarly,
  inhibitors of BCL-2 (eg. Venetoclax) block this BCL-2 inhibitor of apoptosis, sensitising
  cells towards apoptosis. Inhibitors of the PI3K/Akt pro-survival pathway both culminate
  in preventing Akt activation (which inhibits apoptosis), thereby also sensitising
  cells towards apoptosis. Immune-based therapies such as immune checkpoint (IC) inhibitors
  and toll-like receptor (TLR) agonists may enhance immune-mediated killing of HIV-expressing
  cells. IC inhibitors (e.g. anti-PD1 or anti-CTLA-4) also block negative signalling
  to T cells and may potentially also reverse latency. TLR 7/9 agonists bind to receptors
  on endolysosomes in antigen-presenting cells and other immune cells, activate dendritic
  cells (DCs) and natural killer (NK) cells and induce release of interferon-α.SMAC:
  second mitochondria-derived activator of caspase, PI3Ki: phosphoinositide 3-kinase
  inhibitor, Akti: Akt inhibitor, BCL-2i: B-cell lymphoma 2 inhibitor, BETi: bromodomain
  and extra-terminal protein inhibitor, P-TEFb: positive transcription elongation
  factor b, LTR: HIV long terminal repeat promoter, Ac: acetylation, Me: methylation.'
pmcid: PMC5301050
papertitle: Cancer Therapies in HIV Cure Research.
reftext: Thomas A Rasmussen, et al. Curr Opin HIV AIDS. ;12(1):96-104.
pmc_ranked_result_index: '201090'
pathway_score: 0.9538676
filename: nihms841624f1.jpg
figtitle: Cancer Therapies in HIV Cure Research
year: ''
organisms:
- Mus musculus
- Hepatitis B virus
- Human immunodeficiency virus 1
- Macaca mulatta
- Homo sapiens
ndex: fe35905c-deed-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5301050__nihms841624f1.html
  '@type': Dataset
  description: 'Latency reversing agents (LRAs) that induce HIV expression in latently
    infected cells include histone deacetylase inhibitors (HDACi), bromodomain and
    extra-terminal (BET) inhibitors, methylation inhibitors and protein kinase C (PKC)
    agonists. HDACi promote histone acetylation and chromatin remodelling at the HIV
    promoter to support access for transcription initiation. Methylation inhibitors
    prevent deleterious hypermethylation of CpG islands near the HIV promoter to foster
    HIV transcription initiation. PKC agonists (eg. prostratin, bryostatin) promote
    the accumulation of active cellular NF-κB transcription factor in the cell nucleus
    to promote HIV transcription initiation. Bromodomain inhibitors (eg. JQ1) prevent
    PTEF-b binding to bromodomain proteins, releasing free PTEF-b to interact with
    HIV Tat protein for efficient HIV transcription elongation. Apoptosis-inducing
    compounds act on various pathways leading to caspase activation and apoptosis
    and could also be administered with LRAs to sensitise cells for apoptosis. For
    instance, acitretin triggers retinoic acid-inducible gene I (RIG-I) that in turn
    detects viral RNA for subsequent interferon-induced apoptosis. SMAC mimetics block
    inhibitor of apoptosis (IAP) proteins, preventing IAPs from inhibiting apoptosis
    and sensitizing cells towards apoptosis. Similarly, inhibitors of BCL-2 (eg. Venetoclax)
    block this BCL-2 inhibitor of apoptosis, sensitising cells towards apoptosis.
    Inhibitors of the PI3K/Akt pro-survival pathway both culminate in preventing Akt
    activation (which inhibits apoptosis), thereby also sensitising cells towards
    apoptosis. Immune-based therapies such as immune checkpoint (IC) inhibitors and
    toll-like receptor (TLR) agonists may enhance immune-mediated killing of HIV-expressing
    cells. IC inhibitors (e.g. anti-PD1 or anti-CTLA-4) also block negative signalling
    to T cells and may potentially also reverse latency. TLR 7/9 agonists bind to
    receptors on endolysosomes in antigen-presenting cells and other immune cells,
    activate dendritic cells (DCs) and natural killer (NK) cells and induce release
    of interferon-α.SMAC: second mitochondria-derived activator of caspase, PI3Ki:
    phosphoinositide 3-kinase inhibitor, Akti: Akt inhibitor, BCL-2i: B-cell lymphoma
    2 inhibitor, BETi: bromodomain and extra-terminal protein inhibitor, P-TEFb: positive
    transcription elongation factor b, LTR: HIV long terminal repeat promoter, Ac:
    acetylation, Me: methylation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP14
  - ACACA
  - CASP12
  - IL10
  - BCL2
  - CASP4
  - ADCY10
  - CASP2
  - IL2
  - AKT1
  - AKT2
  - HDAC8
  - HDAC3
  - CASP1
  - ADCY4
  - CD28
  - CD4
  - AKT3
  - CASP10
  - NFKB2
  - ADCY6
  - CD8A
  - NFKB1
  - HDAC2
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNG
  - PRKCE
  - PRKCG
  - CD8B
  - CD80
  - REL
  - CASP3
  - CASP5
  - CASP6
  - CASP7
  - CASP8
  - CASP9
  - PRKCB
  - PRKCD
  - IFNA2
  - IFNA4
  - IFNA5
  - ADCY1
  - CD86
  - CTLA4
  - HDAC1
  - DDX58
  - DIABLO
  - TRA
  - TRB
  - TRD
  - IFNA1
  - TNF
  - TGFB2
  - TGFB1
  - TGFB3
  - ADCY2
  - ADCY7
  - ADCY8
  - ADCY9
  - TLR4
  - TLR5
  - TLR10
  - TLR7
  - TLR9
  - TRG
  - PRKCI
  - RELA
  - RELB
  - PRKCH
  - CD274
  - PRKD3
  - PRKCA
  - PDCD1
  - TLR6
  - IFNA6
  - PRKCQ
  - PRKCZ
  - IFNA10
  - TLR3
  - TLR2
  - ADCY3
  - ADCY5
  - IFNA8
  - TLR1
  - IFNA7
  - TLR8
  - Acitretin
  - Cancer
  - Rheumatoid arthritis
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: AcAc
  symbol: ACAC
  source: hgnc_prev_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: BCL-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: CD4+
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: CD8.
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: IFNY
  symbol: IFNG
  source: hgnc_symbol
  hgnc_symbol: IFNG
  entrez: '3458'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: CD8.
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: CD80/86
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: CD80/86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
- word: RIG-I
  symbol: RIG-I
  source: hgnc_alias_symbol
  hgnc_symbol: DDX58
  entrez: '23586'
- word: Smac
  symbol: SMAC
  source: hgnc_alias_symbol
  hgnc_symbol: DIABLO
  entrez: '56616'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: TNFA
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR7/9
  symbol: TLR7
  source: hgnc_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR7/9
  symbol: TLR9
  source: hgnc_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
chemicals:
- word: Acitretin
  source: MESH
  identifier: D017255
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Rheumatoid arthritis
  source: ''
  identifier: ''
figid_alias: PMC5301050__F1
redirect_from: /figures/PMC5301050__F1
figtype: Figure
---
